11 – 20 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Risk and outcomes of COVID-19 in patients with oxygen-dependent chronic respiratory failure– a national cohort study
(
- Contribution to journal › Article
-
Mark
Biologics in severe asthma : A pragmatic approach for choosing the right treatment for the right patient
(
- Contribution to journal › Article
- 2022
-
Mark
Occupation, socioeconomic status and chronic obstructive respiratory diseases – The EpiLung study in Finland, Estonia and Sweden
(
- Contribution to journal › Article
-
Mark
Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD
(
- Contribution to journal › Scientific review
-
Mark
Emphysema severity index (ESI) associated with respiratory death in a large Swedish general population
(
- Contribution to journal › Article
- 2021
-
Mark
Hypoxemia severity and survival in ILD and COPD on long-term oxygen therapy – The population-based DISCOVERY study
(
- Contribution to journal › Article
-
Mark
Efficacy of mepolizumab in usual clinical practice and characteristics of responders : Mepolizumab in usual clinical practice
(
- Contribution to journal › Article
-
Mark
Lung function is associated with tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in school-aged children
(
- Contribution to journal › Article
-
Mark
Fibroblast growth factor 23 is an independent marker of COPD and is associated with impairment of pulmonary function and diffusing capacity
(
- Contribution to journal › Article
-
Mark
The association between carotid-femoral pulse-wave velocity and lung function in the Swedish CArdioPulmonary bioImage study (SCAPIS) cohort
(
- Contribution to journal › Article